Categories Uncategorized

Why You Should Not Fear Digital Health Tech

The technological advancements in the health sector have raised a lot of concerns and fear, especially in bioethics. However, the new improvements in the health sector are inevitable; thus, the fear of the unknown should be a thing of the past. People should not be afraid but rather embrace new digital health technologies. The following discussion should eliminate that fear from people:

Is there any possibility that artificial intelligence can control our lives?

It is surprising how quick research into artificial intelligence and its application is developing. Through it, some researchers are aiming at creating a cloud-based data sharing center. The cloud-based data system is to help physicians to utilize the vast amount of data to come up with better diagnostics and care. Besides, the invention will have the capability of reading millions of documents in seconds and provide the most suitable therapies.

However, the biggest fear is that will artificial intelligence work better than the human brain and take control of lives? That should not be the case as it only aims at helping and developing healthcare for better services.

Would surgical robots become uncontrollable and injure patients?

The use of robotics has improved surgical procedures. It has contributed to more successful operations and faster healing. For instance, the da Vinci surgical system has enabled physicians to operate with precision, enhanced vision and much control. Despite all those advantages of robotic operation, people still fear that these machines may become uncontrollable and cause harm.

People should not have that fear as human beings control these machines. Technology is there to assist surgeons. Therefore, people should not fear but rather embrace new technologies.

Are wearable devices reliable?

Wearables and sensors have become more popular globally. Devices such as Viatom Checkme and Scanadu that measures your heart rate, oxygen saturation and temperature among others have transformed healthcare. However, a lot of people still do not have sufficient information about the accuracy of these devices. Some people also do not know how to use them without guidance from an expert.

It is therefore essential for the device manufacturers to give clear instructions on how to use them. They also need to come up with quality devices that meet FDA standards.

Will nanobots give more room to bioterrorism?

Researchers have been doing experiments with micro-sized robots that could swim into body fluids to deliver drugs in some targeted areas. They are so tiny that they cannot be discovered when swallowed. Some people are afraid since by using such small devices, security could be compromised hence leading to bioterrorism. However, ethical controls are put in place to curb such vices.

Is there any chance that genome sequencing can reveal your fate?

Genome sequencing is an amazing tool to prevent and cure diseases. Besides, when it is used carefully and wisely, putting bioethics measures in place, it can save lives. However, the essential thing to dissolve fear among people is educating them and making them aware of how it works. They should also be informed about the pros and cons of genome sequencing. Genome sequencing doesn’t provide conclusive proof about your future. It simply predicts what could happen, and other factors can determine whether this comes to pass or not.

As digital health technology plays a bigger role, the public will come to trust these systems more as they will witness how valuable they are. Entities like LexaGene Holdings Inc. (TSX.V: LXG) (OTCQB: LXXGF) are undoubtedly doing the best they can to stamp their mark on this medical revolution.

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Adageis Offering Comprehensive Healthcare AI Tools to Support Profitable Shift to Value-Based Care

Adageis offers an AI-powered financial technology platform tailored to healthcare providers seeking a financially positive…

7 hours ago

Scientists ID Bacteria That Could Be Behind Multiple Sclerosis Development

A new study focusing on twins has found that individuals with a larger presence of…

7 hours ago

How Stem Cells Help in Blood Cancer Treatment

Stem cells are the “master cells” within the body because they can grow into any…

1 day ago

UnitedHealth Records Lower Revenue as Medical Advantage Use Grows

UnitedHealth Group, the largest health insurance firm in the U.S., has reduced its revenue forecast…

3 days ago

Nutriband Inc. (NASDAQ: NTRB): Building a Moat Around Abuse-Deterrent Drug Delivery

Nutriband secures new U.S. trademark and international patents for AVERSA(TM) platform AVERSA(TM) Fentanyl targets $80M–$200M…

3 days ago

Soligenix Inc. (NASDAQ: SNGX) Advances CiVax Amid Ongoing COVID-19 Threat

An increase in deaths from COVID-19 underscores the persistent danger of the virus and the…

4 days ago